Family · Pharmaceutical analytical standards
Isavuconazole
A triazole antifungal for invasive fungal infections such as aspergillosis and mucormycosis; it is given as isavuconazonium, a water-soluble prodrug that esterases rapidly convert into the active drug. It was approved in 2015 in the US and Europe. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The molecule was discovered in Japan, at a research centre in Kamakura, and in the US it received orphan drug designation for both invasive aspergillosis and mucormycosis.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
